期刊
TRENDS IN BIOTECHNOLOGY
卷 37, 期 1, 页码 86-99出版社
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tibtech.2018.07.014
关键词
-
资金
- Swiss National Foundation [310030-120473]
- Medic foundation
- Swiss National Science Foundation (SNF) [310030-120473] Funding Source: Swiss National Science Foundation (SNF)
In 2006, the group of Dr C.M. Lieber pioneered the field of nanowire sensors by fabricating devices for the ultra-sensitive label-free detection of biological macromolecules. Since then, nanowire sensors have demonstrated their ability to detect cancer-associated analytes in peripheral blood, tumor tissue, and the exhaled breath of cancer patients. These innovative developments have marked a new era with unprecedented detection performance, capable of addressing crucial needs such as cancer diagnosis and monitoring disease progression and patient response to therapy. The ability of nanowire sensors to identify molecular features of patient tumor represents a first step toward precision medicine, and their integration into portable devices has the potential to revolutionize cancer diagnosis and patient monitoring.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据